1995
DOI: 10.1074/jbc.270.45.26950
|View full text |Cite
|
Sign up to set email alerts
|

Serum Amyloid P Component Binding to C4b-binding Protein

Abstract: Human C4b-binding protein (C4BP), which is a regulator of the classical complement pathway C3 convertase, forms high affinity complexes with anticoagulant protein S and with the pentraxin serum amyloid P component (SAP). SAP is a plasma protein present in all amyloid deposits. Recently, SAP was shown to inhibit the complement regulatory functions of C4BP. In this investigation, we have studied the structural requirements for the C4BP-SAP interaction. C4BP was subjected to chymotrypsin digestion, which yielded … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
57
3

Year Published

1998
1998
2017
2017

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 71 publications
(60 citation statements)
references
References 45 publications
0
57
3
Order By: Relevance
“…We have found that the CCP6 domain of C4BP (55), structural arrangements in the polymeric C4BP spatial conformation because of the presence of ProS either by an allosteric mechanism or by direct steric hindrance might: 1) preclude a direct interaction of the CCP6 domain from the a-chains with the putative "tolerogenesis" receptor on DCs, or 2) reduce the overall avidity of polymeric C4BP binding to the receptor through the CCP6 domain. In this respect, although the C4BP(b + )-ProS complex attached to apoptotic cells through ProS is still able to bind C4b through domains CCP1-3 of the a-chains (23), serum amyloid P binding to the central core linking the seven or eight chains impairs its factor I cofactor activity (56). Nevertheless, further structure-activity studies will be necessary to dissect the relationship between structure and function of polymeric C4BP on DCs.…”
Section: Discussionmentioning
confidence: 99%
“…We have found that the CCP6 domain of C4BP (55), structural arrangements in the polymeric C4BP spatial conformation because of the presence of ProS either by an allosteric mechanism or by direct steric hindrance might: 1) preclude a direct interaction of the CCP6 domain from the a-chains with the putative "tolerogenesis" receptor on DCs, or 2) reduce the overall avidity of polymeric C4BP binding to the receptor through the CCP6 domain. In this respect, although the C4BP(b + )-ProS complex attached to apoptotic cells through ProS is still able to bind C4b through domains CCP1-3 of the a-chains (23), serum amyloid P binding to the central core linking the seven or eight chains impairs its factor I cofactor activity (56). Nevertheless, further structure-activity studies will be necessary to dissect the relationship between structure and function of polymeric C4BP on DCs.…”
Section: Discussionmentioning
confidence: 99%
“…C4BP has previously been reported to bind to serum amyloid P component (SAP) (22), which is a member of the pentraxin family and has an overall structure strikingly similar to that of CRP. SAP is one of the major acute phase reactants in mice.…”
Section: Discussionmentioning
confidence: 99%
“…Recombinant C4BP (20), monomeric C4BP ␣-chains (21), and the C4BP central core region (22) were expressed or prepared as described. Recombinant C4BP (C4BPrec) and its truncated form composed of CCP1-8 were expressed in HEK 293 cells and purified by affinity chromatography using mAb 104 directed against CCP1 of the C4BP ␣-chain (20).…”
Section: Methodsmentioning
confidence: 99%
“…First, we tested whether C4BP purified from plasma consisting of seven ␣-chains and one ␤-chain will bind pili with the same apparent affinity as the recombinant C4BP that is composed exclusively of ␣-chains. ␣-Chains are known to bind C4b (17), heparin (41), Bordetella pertussis (24), Streptococcus pyogenes (23), and serum amyloid P component (42), whereas ␤-chain binds anticoagulant protein S (18). We found that both forms of C4BP bound to pili with similar affinities, implying that ␣-chains confer the ability to bind gonococcal pili.…”
Section: Discussionmentioning
confidence: 99%